Liposomal Cytarabine clinical trials
A product of Cytarabine; its studies count on that page too.
How each study uses Liposomal Cytarabine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 1 Apr 1999 · DEPOCYT · NDA 021041 (FDA, Drugs@FDA)
- European Union
- 11 Jul 2001 · DepoCyte · EMEA/H/C/000317 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
19 studies that test it; most in 2009 (4)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 1997 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2011 | 3 |
| 2012 | 2 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 18
Goethe University (2) · PETHEMA Foundation (2) · International Extranodal Lymphoma Study Group (IELSG) (1) · Andrés José Maria Ferreri (1) · Nordic Lymphoma Group (1) · Centre Oscar Lambret (1) · University of Washington (1) · Northern Italy Leukemia Group (1)
Often tested with
Tested in the same studies.
Methotrexate (4) · Cyclophosphamide (3) · Vincristine (3) · Rituximab (2) · Prednisolone (2) · Dexamethasone (2) · Mercaptopurine (2) · Asparaginase (2)
Related medicines
As reviewed, each with the page that says it.
- A dosage form of Cytarabine
- One of Antimetabolites source
Studies
Open first, then newest update. How each study uses Liposomal Cytarabine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 19
- Safety and Feasibility Study of Combination of State of Art Chemoimmunotherapy, Intensive Central Nervous System Prophylaxis and Scrotal Irradiation to Treat Primary Diffuse Large B-cell Lymphoma of TestisCompletedPhase 2International Extranodal Lymphoma Study Group (IELSG)NCT00945724Written as Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone, liposomal cytarabine, methotrexateHow we know
- High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System InvolvementCompletedPhase 2Andrés José Maria FerreriNCT00801216Written as High-dose sequential chemotherapy and autologous transplantHow we know
- Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in ChildrenStatus unknownPhase 2National Cancer Institute, NaplesNCT01593488Written as liposomal cytarabineHow we know
- German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedPhase 4Goethe UniversityNCT00198978Written as DepocyteHow we know
- Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With DepocytCompletedPhase 2/3Goethe UniversityNCT00199108Written as DepocytHow we know
- Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic LymphomaTerminatedPhase 2University of California, San DiegoNCT02043587Written as Liposomal AraCHow we know
- CHemoImmunotherapy With Early Central Nervous System (CNS) ProphylaxisCompletedPhase 2Nordic Lymphoma GroupNCT01325194Written as liposomal cytarabineHow we know
- Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast CancerCompletedPhase 3Centre Oscar LambretNCT01645839Written as Liposomal CytarabineHow we know
- Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast CancerCompletedPhase 2University of WashingtonNCT00992602Written as liposomal cytarabineHow we know
- A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the BrainTerminatedPhase 1University Hospital, BonnNCT01563614Written as Liposomal cytarabineHow we know
- PROCEDYTE: Depocyte® Administration (Liposomal Cytarabine) as Prophylaxis of Neuromeningeal Infiltration in Acute Lymphoblastic LeukemiaTerminatedPhase 3PETHEMA FoundationNCT00944008Written as DepoCyteHow we know
- Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic LeukemiaCompletedPhase 2/3Northern Italy Leukemia GroupNCT00795756Written as liposome-encapsulated cytarabine (DepoCyte)How we know
- Depocyt® With Sorafenib in Neoplastic MeningitisTerminatedNot applicableH. Lee Moffitt Cancer Center and Research InstituteNCT00964743Written as DepoCytHow we know
- DepoCyt for Active Lymphomatous or Leukemic MeningitisTerminatedPhase 2Duke UniversityNCT00523939Written as cytarabine liposome injectionHow we know
- Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic LeukemiaCompletedPhase 2National Cancer Institute (NCI)NCT00002704Written as liposomal cytarabineHow we know
- Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)SuspendedPhase 3Nordic Society for Pediatric Hematology and OncologyNCT00991744Written as Liposomal cytarabineHow we know
- DepoCyt Plus Temozolomide in Patients With Neoplastic MeningitisTerminatedPhase 1M.D. Anderson Cancer CenterNCT00515788Written as DepoCytHow we know
- Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive LymphomaCompletedPhase 2PETHEMA FoundationNCT00388531Written as Depocyte®How we know
- Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid TumorsStatus unknownPhase 1Pacira Pharmaceuticals, IncNCT00003073Written as liposomal cytarabineHow we know
Given beside what is tested · 3 — Liposomal Cytarabine is usual care or a partner of the new treatment
- Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHLRecruitingPhase 2New York Medical CollegeNCT02393157Written as Liposomal ARA-CHow we know
- Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's LymphomaCompletedPhase 2AIDS Malignancy ConsortiumNCT00392834Written as liposomal cytarabineHow we know
- Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's LymphomaCompletedPhase 2Beth Israel Deaconess Medical CenterNCT00073957Written as liposomal cytarabineHow we know